chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, COVID-19, Chills, Cough, Headache
Clinical narrative: I contracted COVID-19. I had a high fever of 104 for over a week, sore throat, body aches, cough, chills, night sweats, headache, and I lost my sense of smell. My heart would race as well. I did not get PAXLOVID because my doctor said it would interact with the anti-depressant I was on. I just took TYLENOL and ADVIL instead. The doctor said that I now have long COVID-19. I was diagnosed with Tachycardia and I have heart palpitations. I am under the care of a cardiologist now.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Night sweats, Oropharyngeal pain, Pain, Palpitations, Post-acute COVID-19 syndrome
Clinical narrative: I contracted COVID-19. I had a high fever of 104 for over a week, sore throat, body aches, cough, chills, night sweats, headache, and I lost my sense of smell. My heart would race as well. I did not get PAXLOVID because my doctor said it would interact with the anti-depressant I was on. I just took TYLENOL and ADVIL instead. The doctor said that I now have long COVID-19. I was diagnosed with Tachycardia and I have heart palpitations. I am under the care of a cardiologist now.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Tachycardia
Clinical narrative: I contracted COVID-19. I had a high fever of 104 for over a week, sore throat, body aches, cough, chills, night sweats, headache, and I lost my sense of smell. My heart would race as well. I did not get PAXLOVID because my doctor said it would interact with the anti-depressant I was on. I just took TYLENOL and ADVIL instead. The doctor said that I now have long COVID-19. I was diagnosed with Tachycardia and I have heart palpitations. I am under the care of a cardiologist now.
Age: 53.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Aphonia, COVID-19, Chills, Cough, Gastrointestinal disorder
Clinical narrative: My arm was sore for about one day. I did not receive any treatment. I also experienced COVID-19 around 11/21/2022. I really had a bad cold, symptoms lasting about one week I tested positive for two weeks. I tested positive for COVID-19 on 11/26/2022. I also got sick twice again and it felt a lot worse in end of February 2023 and April 2023. I tested for COVID-19 and it was negative in these months. On 02/27/2023 I lost my voice about two weeks and had a terrible couch, chills, fever, nausea and also gastrointestinal issues ever since getting COVID-19. I took prednisone for 5 days which helped a lot but one month later I got sick again and it took 2-3 weeks for my symptoms to go away.
Age: 53.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Malaise, Nasopharyngitis, Nausea, Pain in extremity, Pyrexia
Clinical narrative: My arm was sore for about one day. I did not receive any treatment. I also experienced COVID-19 around 11/21/2022. I really had a bad cold, symptoms lasting about one week I tested positive for two weeks. I tested positive for COVID-19 on 11/26/2022. I also got sick twice again and it felt a lot worse in end of February 2023 and April 2023. I tested for COVID-19 and it was negative in these months. On 02/27/2023 I lost my voice about two weeks and had a terrible couch, chills, fever, nausea and also gastrointestinal issues ever since getting COVID-19. I took prednisone for 5 days which helped a lot but one month later I got sick again and it took 2-3 weeks for my symptoms to go away.
Age: 53.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: SARS-CoV-2 test positive
Clinical narrative: My arm was sore for about one day. I did not receive any treatment. I also experienced COVID-19 around 11/21/2022. I really had a bad cold, symptoms lasting about one week I tested positive for two weeks. I tested positive for COVID-19 on 11/26/2022. I also got sick twice again and it felt a lot worse in end of February 2023 and April 2023. I tested for COVID-19 and it was negative in these months. On 02/27/2023 I lost my voice about two weeks and had a terrible couch, chills, fever, nausea and also gastrointestinal issues ever since getting COVID-19. I took prednisone for 5 days which helped a lot but one month later I got sick again and it took 2-3 weeks for my symptoms to go away.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE ST ELEVATION MI, ANTERIOR WALL
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Eye pain, Lymphadenopathy, Ocular hyperaemia, Periorbital swelling, Swelling of eyelid
Clinical narrative: My child started to complain that her eyes hurt around 5:15pm. I brushed it off and didn't look at them as she was in another room in the house and I was cooking dinner. She kept complaining and finally came into the kitchen about 15 min later and her left eye was swollen almost shut and her right eye was swollen halfway shut. I immediately gave her Benadryl. I called the on call and they said to take her to ER or Urgent Care.  My husband and I decided to see if benadryl worked first. Her lymph nodes in her neck were swollen but she lips and tongue were not and she was not having trouble breathing. It took about 30 min for the symptoms to Start subsiding. The redness went down first then the swelling stopped increasing. About 3 hours later she went to bed. The swelling was still there but was not nearly as bad. In the morning her eyes were puffy, and by 24 hours later  (since the swelling started) she looked normal again. She did not cry at the doctors office or have any reason that her eyes would be red and puffy.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Ischaemia, Ischaemic stroke
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Pain, Quarantine, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: After my COVD - 19 vaccination I developed  a break through case of COVID - 19. I experienced body aches and pain and consulted with my telehealth specialist.  After the consultation I tested at home and the test was positive.  I quarantined for 10 days at the advice of my physician and recovered.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Reversible ischaemic neurological deficit, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME HYPOTENSION  11/15/2022  --  RECURRENCE OF SAME SYMPTOMS
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Obstructive pancreatitis, SARS-CoV-2 test positive
Clinical narrative: Pt was admitted on 4/26 with gallstone pancreatitis and COVID pneumonia. She was found to be COVID positive in the ER prior to transfer.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Chills, Cough, Multiple sclerosis
Clinical narrative: Pt has a cough, body aches, chills, nausea, and vomiting for 10 days. She is admitted with COVID-19 with acute hypoxic respiratory failure, secondary bacterial pneumonia, and MS.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Pain, Pneumonia bacterial, Vomiting
Clinical narrative: Pt has a cough, body aches, chills, nausea, and vomiting for 10 days. She is admitted with COVID-19 with acute hypoxic respiratory failure, secondary bacterial pneumonia, and MS.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Acute respiratory failure, Anaemia of chronic disease, Diabetic vascular disorder, Hypotension
Clinical narrative: G62.9 PERIPHERAL NEUROPATHY 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I95.9 HYPOTENSION 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 DM 2 W PERIPHERAL VASCULAR DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R09.02 HYPOXIA 10/28/2021 DM 2 W PERIPHERAL VASCULAR DISEASE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R57.9 SHOCK, UNSPECIFIED 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I95.9 HYPOTENSION 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 DM 2 W PERIPHERAL VASCULAR DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R09.02 HYPOXIA 10/28/2021 DM 2 W PERIPHERAL VASCULAR DISEASE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R57.9 SHOCK, UNSPECIFIED 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 ANEMIA OF CHRONIC DISEASE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 ANEMIA OF CHRONIC DISEASE I95.9 HYPOTENSION 1/3/2022 ANEMIA OF CHRONIC DISEASE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 ANEMIA OF CHRONIC DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 ANEMIA OF CHRONIC DISEASE R09.02 HYPOXIA 10/28/2021 ANEMIA OF CHRONIC DISEASE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 ANEMIA OF CHRONIC DISEASE R57.9 SHOCK, UNSPECIFIED 1/3/2022 ANEMIA OF CHRONIC DISEASE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE I95.9 HYPOTENSION 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE R09.02 HYPOXIA 10/28/2021 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE R57.9 SHOCK, UNSPECIFIED 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 HYPOTHYROIDISM I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 HYPOTHYROIDISM I95.9 HYPOTENSION 1/3/2022 HYPOTHYROIDISM J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 HYPOTHYROIDISM J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 HYPOTHYROIDISM R09.02 HYPOXIA 10/28/2021 HYPOTHYROIDISM R57.1 HYPOVOLEMIC SHOCK 1/3/2022 HYPOTHYROIDISM R57.9 SHOCK, UNSPECIFIED 1/3/2022 HYPOTHYROIDISM
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Hypothyroidism, Hypovolaemic shock, Hypoxia, Neuropathy peripheral, Peripheral vascular disorder
Clinical narrative: G62.9 PERIPHERAL NEUROPATHY 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I95.9 HYPOTENSION 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 DM 2 W PERIPHERAL VASCULAR DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R09.02 HYPOXIA 10/28/2021 DM 2 W PERIPHERAL VASCULAR DISEASE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R57.9 SHOCK, UNSPECIFIED 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I95.9 HYPOTENSION 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 DM 2 W PERIPHERAL VASCULAR DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R09.02 HYPOXIA 10/28/2021 DM 2 W PERIPHERAL VASCULAR DISEASE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R57.9 SHOCK, UNSPECIFIED 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 ANEMIA OF CHRONIC DISEASE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 ANEMIA OF CHRONIC DISEASE I95.9 HYPOTENSION 1/3/2022 ANEMIA OF CHRONIC DISEASE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 ANEMIA OF CHRONIC DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 ANEMIA OF CHRONIC DISEASE R09.02 HYPOXIA 10/28/2021 ANEMIA OF CHRONIC DISEASE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 ANEMIA OF CHRONIC DISEASE R57.9 SHOCK, UNSPECIFIED 1/3/2022 ANEMIA OF CHRONIC DISEASE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE I95.9 HYPOTENSION 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE R09.02 HYPOXIA 10/28/2021 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE R57.9 SHOCK, UNSPECIFIED 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 HYPOTHYROIDISM I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 HYPOTHYROIDISM I95.9 HYPOTENSION 1/3/2022 HYPOTHYROIDISM J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 HYPOTHYROIDISM J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 HYPOTHYROIDISM R09.02 HYPOXIA 10/28/2021 HYPOTHYROIDISM R57.1 HYPOVOLEMIC SHOCK 1/3/2022 HYPOTHYROIDISM R57.9 SHOCK, UNSPECIFIED 1/3/2022 HYPOTHYROIDISM
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Shock, Type 2 diabetes mellitus
Clinical narrative: G62.9 PERIPHERAL NEUROPATHY 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I95.9 HYPOTENSION 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 DM 2 W PERIPHERAL VASCULAR DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R09.02 HYPOXIA 10/28/2021 DM 2 W PERIPHERAL VASCULAR DISEASE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R57.9 SHOCK, UNSPECIFIED 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE I95.9 HYPOTENSION 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 DM 2 W PERIPHERAL VASCULAR DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R09.02 HYPOXIA 10/28/2021 DM 2 W PERIPHERAL VASCULAR DISEASE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE R57.9 SHOCK, UNSPECIFIED 1/3/2022 DM 2 W PERIPHERAL VASCULAR DISEASE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 ANEMIA OF CHRONIC DISEASE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 ANEMIA OF CHRONIC DISEASE I95.9 HYPOTENSION 1/3/2022 ANEMIA OF CHRONIC DISEASE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 ANEMIA OF CHRONIC DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 ANEMIA OF CHRONIC DISEASE R09.02 HYPOXIA 10/28/2021 ANEMIA OF CHRONIC DISEASE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 ANEMIA OF CHRONIC DISEASE R57.9 SHOCK, UNSPECIFIED 1/3/2022 ANEMIA OF CHRONIC DISEASE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE I95.9 HYPOTENSION 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE R09.02 HYPOXIA 10/28/2021 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE R57.1 HYPOVOLEMIC SHOCK 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE R57.9 SHOCK, UNSPECIFIED 1/3/2022 PERIPHERAL VASCULAR DISEASE, UNSPECIFIED TYPE G62.9 PERIPHERAL NEUROPATHY 1/3/2022 HYPOTHYROIDISM I21.4 ACUTE NON ST ELEVATION MI 1/3/2022 HYPOTHYROIDISM I95.9 HYPOTENSION 1/3/2022 HYPOTHYROIDISM J96.00 ACUTE RESPIRATORY FAILURE 11/8/2021 HYPOTHYROIDISM J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/3/2022 HYPOTHYROIDISM R09.02 HYPOXIA 10/28/2021 HYPOTHYROIDISM R57.1 HYPOVOLEMIC SHOCK 1/3/2022 HYPOTHYROIDISM R57.9 SHOCK, UNSPECIFIED 1/3/2022 HYPOTHYROIDISM
Age: 60.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Anosmia, COVID-19, Malaise, Pain, Pyrexia
Clinical narrative: I started to feel sick on 02/22/2023. I tested positive for COVID-19 on 02/23/2023. I had a telehealth visit on 02/23/2023 spoke to a physical assistant and they gave me a prescription for PAXLOVID and took the course of this medication which made me feel better. I had a very quick onset of fever and body aches. I also did lose my sense of smell. I took a home test on 02/23/2023 which was positive. I continued to test positive for 10-11 days. On the 11th day I tested negative which was on 03/06/2023. I am always complying with masking requests.
Age: 60.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I started to feel sick on 02/22/2023. I tested positive for COVID-19 on 02/23/2023. I had a telehealth visit on 02/23/2023 spoke to a physical assistant and they gave me a prescription for PAXLOVID and took the course of this medication which made me feel better. I had a very quick onset of fever and body aches. I also did lose my sense of smell. I took a home test on 02/23/2023 which was positive. I continued to test positive for 10-11 days. On the 11th day I tested negative which was on 03/06/2023. I am always complying with masking requests.
Age: 56.0
Sex: M
Vaccine: VARZOS
Symptoms: Abdominal distension, Abdominal pain upper, Computerised tomogram abdomen abnormal, Computerised tomogram liver abnormal, Computerised tomogram of gallbladder
Clinical narrative: Patient received shingles vaccine on 4/23/23 then the following morning he had stomach pain which is a common side effect of shingrix and believed that was all that is. By that afternoon patient stated pain was too severe and went into the emergency department. Received multiple injections of narcotics throughout their stay. Was put on oral norco every 4 hours and IV Fentanyl for the pain. Patient received a CT scan of pancreas/gallbladder/liver (upper right abdominal quadrant). Swelling and inflammation were found. Patient had lipid and lipase panel run and lipase levels were 13,000 at the highest point. Was on clear liquids and IV from Tuesday through Thursday. Friday was able to switch over to non-clear and later was discharged.
Age: 56.0
Sex: M
Vaccine: VARZOS
Symptoms: Computerised tomogram pancreas abnormal, Inflammation, Lipase increased
Clinical narrative: Patient received shingles vaccine on 4/23/23 then the following morning he had stomach pain which is a common side effect of shingrix and believed that was all that is. By that afternoon patient stated pain was too severe and went into the emergency department. Received multiple injections of narcotics throughout their stay. Was put on oral norco every 4 hours and IV Fentanyl for the pain. Patient received a CT scan of pancreas/gallbladder/liver (upper right abdominal quadrant). Swelling and inflammation were found. Patient had lipid and lipase panel run and lipase levels were 13,000 at the highest point. Was on clear liquids and IV from Tuesday through Thursday. Friday was able to switch over to non-clear and later was discharged.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Atrial fibrillation, COVID-19, Cardiac failure, Cardiac failure congestive, SARS-CoV-2 test positive
Clinical narrative: Pt admitted on 4/23 with afib, tachycardia, and biventricular heart failure. On 4/29 he had a COVID test for SNF placement that was positive despite being asymptomatic.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Tachycardia
Clinical narrative: Pt admitted on 4/23 with afib, tachycardia, and biventricular heart failure. On 4/29 he had a COVID test for SNF placement that was positive despite being asymptomatic.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received  Pfizer monovalent primary series (5-11Yrs) second dose.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Chronic respiratory failure, Respiratory failure
Clinical narrative: Pfizer vaccine was administered outside of clinic- reported by patient- ? NO LOT NUMBER WERE SUPPLIED   CHRONIC HYPOXEMIC RESPIRATORY FAILURE 6/10/2022 ACUTE RENAL FAILURE, UNSPECIFIED
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Syringe issue
Clinical narrative: syringe failure when administering vaccine, While administering vaccine of , it leaked out between the needle and the barrel. possibly  1/2 dose. Per guidelines gave another 1/2 dose immediately after.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypotension
Clinical narrative: I95.9 HYPOTENSION 1/29/2022 HYPOTENSION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/29/2022 HYPOTENSION
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Expired product administered
Clinical narrative: Expired vaccine given
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  HYPOTENSION  5/10/2022 --  RECURRENCE OF SAME SYMPTOMS
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Femoral neck fracture, Product lot number issue, Pulmonary embolism, Urinary tract infection
Clinical narrative: Pfizer vaccine was administered outside of our facility - reported by patient- ? NO LOT NUMBER WERE SUPPLIED  I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 12/17/2021 RIGHT FEMORAL NECK UNSPECIFIED TYPE FX, INIT I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 12/17/2021 UTI (URINARY TRACT INFECTION)
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive for Covid-19 on 11/22/22, was hospitalized on 12/4/22, and subsequently died on 12/20/22.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Behaviour disorder, COVID-19, Cerebrovascular accident, Confusional state
Clinical narrative: pt to hospital with mental status and behavior changes, confusion, disorientation, weakness; positive for COVID; not hypoxic, therefore, no COVID treatment; stroke, not a tPA candidate; stayed in hosp x 4 days;  dc'd to home with home health (the name of the agency is not in the medical records; pt brought back to hospital on 10/11/22 where pt passed away
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Disorientation, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: pt to hospital with mental status and behavior changes, confusion, disorientation, weakness; positive for COVID; not hypoxic, therefore, no COVID treatment; stroke, not a tPA candidate; stayed in hosp x 4 days;  dc'd to home with home health (the name of the agency is not in the medical records; pt brought back to hospital on 10/11/22 where pt passed away
Age: 1.17
Sex: M
Vaccine: COVID19-2, HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: COVID Vaccine was given beyond use date. No adverse reaction noted or seen at time given.
Age: 4.0
Sex: F
Vaccine: DTAP, VARCEL
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Patient and mom came into clinic reporting reaction from vaccine. R arm had an area of redness. No swelling and patient have no complaints of pain.  Mom reports previously it was swollen, and more red. Advised applying cool compress and notify us if sx do not continue to improve. Mom would like guidance on future vaccines She is concerned about receiving future vaccine and would like to avoid receiving another dose of which ever vaccine caused the reaction.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Erythema, Injection site reaction, Lymphadenopathy, Oedema peripheral, Rash vesicular
Clinical narrative: Right lateral thigh ~ 12 cm x 13 cm erythema, increased warmth, mild edema. (+) Central ~ 2.5 cm x 2.5 cm circular vesicolor rash around injection site. Right inguinal fold with enlarged, rubbery lymphatic nodes x2 ~ 0.5 cm diameter each, N/T to palpation.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Skin warm
Clinical narrative: Right lateral thigh ~ 12 cm x 13 cm erythema, increased warmth, mild edema. (+) Central ~ 2.5 cm x 2.5 cm circular vesicolor rash around injection site. Right inguinal fold with enlarged, rubbery lymphatic nodes x2 ~ 0.5 cm diameter each, N/T to palpation.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Motor dysfunction, Pyrexia, Rash, Tremor
Clinical narrative: Received 2nd dose of shingrix 4/7/23 (no issue with first does 1/24/23)  pt reports having fever, chills, rash on admin arm (left)  and across abdomen. after couple days she felt better rash cleared, but her left arm tremors now when she's trying to grip things. other reported conditions include chronic back pain-nerve root disorder.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  OBSTRUCTIVE SLEEP APNEA  11/29/2022 --  RECURRENCE OF SAME SYMPTOMS
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: I had a bad headache lasted for twelve hours. I took TYLENOL and it went away. I have recovered from my symptoms.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abnormal loss of weight, Activated partial thromboplastin time abnormal, Ammonia, Angiogram, Anti-insulin antibody
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Antibiotic level, Arterial disorder, Aspiration bone marrow, Asthenia, Atrial fibrillation
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Biopsy bone marrow, Blood calcium, Blood calcium increased, Blood creatine phosphokinase, Blood creatinine
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood culture, Blood gases, Blood glucose abnormal, Blood grouping, Blood insulin
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood iron abnormal, Blood ketone body, Blood lactic acid abnormal, Blood magnesium abnormal, Blood parathyroid hormone
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood phosphorus abnormal, Blood thyroid stimulating hormone, Blood triglycerides, Blood urea abnormal, Bone lesion
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Calcium ionised, Central venous catheterisation, Chest X-ray, Clostridium test positive, Coagulation time
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Coeliac disease, Computerised tomogram, Computerised tomogram abdomen, Computerised tomogram head, Computerised tomogram limb
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax, Cough, Culture urine, Dialysis, Differential white blood cell count abnormal
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Drug trough level, Echocardiogram, Electrocardiogram, Electrophoresis protein, Endotracheal intubation
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer, Full blood count abnormal, Gait disturbance, Glycosylated haemoglobin, Gram stain
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hepatitis B core antibody, Hepatitis B surface antibody, Hepatitis B surface antigen, Immunology test, Insulin C-peptide
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intensive care, International normalised ratio abnormal, Investigation, Iron binding capacity total abnormal, Light chain analysis
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lipase abnormal, Lipids, Magnetic resonance imaging head, Magnetic resonance imaging neck, Magnetic resonance imaging spinal
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging thoracic, Mammogram, Mesenteric artery stenosis, Metabolic function test abnormal, Microscopy
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Occult blood, Parathyroid hormone-related protein, Peripheral embolism, Platelet count decreased
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Prealbumin, Prothrombin time abnormal, Pulmonary embolism, Red blood cell transfusion, Renal failure
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory failure, Respiratory viral panel, SARS-CoV-2 RNA, SARS-CoV-2 test, Scan with contrast
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sepsis, Serum ferritin, Sinusitis, Sputum culture, Staphylococcus test
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Streptococcus test, Superior mesenteric artery syndrome, Tenderness, Troponin, Troponin I abnormal
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Troponin increased, Ultrasound Doppler, Ultrasound abdomen, Urine analysis, Urine electrolytes
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urine osmolarity, Vitamin D, X-ray limb
Clinical narrative: Pulmonary embolisms in lung/leg, renal failure and put on dialysis, respiratory failure and put on oxygen, Atrial fibrillation in tandem with pulmonary embolisms. Troponin levels extremely high which could lead to myocarditis, etc.  Sepsis, Carotid artery tenderness.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute kidney injury, COVID-19, Cough, Laboratory test abnormal, Malaise
Clinical narrative: discharge summary "Patient is a 72 YO female history of liver cirrhosis from NASH, hypertension presented with cough and malaise. Labs reveal AKI and COVID 19 +. She was admitted for COVID 19 and AKI management. During her stay, she received IVF that resolved her AKI. She was also placed on decadron for her COVID 19 infection. Social worker has given extra resources to help with her financial stress at home. She was discharged in stable condition. Strict return precautions given".
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: discharge summary "Patient is a 72 YO female history of liver cirrhosis from NASH, hypertension presented with cough and malaise. Labs reveal AKI and COVID 19 +. She was admitted for COVID 19 and AKI management. During her stay, she received IVF that resolved her AKI. She was also placed on decadron for her COVID 19 infection. Social worker has given extra resources to help with her financial stress at home. She was discharged in stable condition. Strict return precautions given".
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Anticoagulant therapy, Asthenia, Atrial fibrillation, Bladder mass, Blood creatinine increased
Clinical narrative: Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)    This is a 86 yr old male with PMHx of CKD-3, gout, persistent Afib, HTN, HLD and BPH who presented for generalized weakness and falls.  CT head was negative.  UA showed evidence of infection and Ucx grew 2 strains of E coli so he was started on ceftriaxone.  He had a CT urogram which showed 2 new bladder masses.  Urology was consulted and said workup can be done outpt.  He follows with Urology at other facility and he will decide if he wants to follow up with them or stay here for the workup.  During his stay he developed a gout flare and was started on a steroid taper along with colchicine.  His heart rate was elevated so Toprol dose was increased.  PT/OT recommended SNF.  Pt was stable on discharge.  He will be discharged.     Sepsis 2/2 UTI - elevated wbc and HR - sepsis resolved - Ucx growing E coli 2 strains - continue cefdinir 300mg BID for 3 more days   New bladder masses Hx of bladder cancer - s/p TURBT - CT urogram showed 2 new bladder masses  - follow up with Urology outpt for workup   Elevated Cr on CKD-3 - baseline Cr 1.4 - likely due to poor perfusion in setting of infection  - resolved    Gout flare - evidence of polyarticular disease with tophi - continue prednisone 40mg for 3 days, then 30mg for 3 days then 20mg for 3 days - start colchicine 0.6mg every other day - start allopurinol 100mg daily on 5/6/23 - referral placed to Rheumatology   Afib with RVR - CHADS-VASc- 3 - continue Eliquis 2.5mg BID - increased Toprol to 100mg daily, monitor HR and may need dose reduced   HTN - continue HCTZ 12.5mg daily, lisinopril 10mg nighlty and Toprol   HLD - continue atorvastatin 20mg daily   BPH - s/p HoLEP   Issues Requiring Follow Up: (Who, what, when, and how communicated?)    Follow up with PCP and Urology.  Referral placed to Rheumatology.  Complete 3 more days of antibiotics.  Complete steroid taper.  Start colchicine and allopurinol.  Toprol dose increased, monitor HR for dose adjustments.
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: CHA2DS2-VASc-score, COVID-19, Computerised tomogram head normal, Condition aggravated, Culture urine positive
Clinical narrative: Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)    This is a 86 yr old male with PMHx of CKD-3, gout, persistent Afib, HTN, HLD and BPH who presented for generalized weakness and falls.  CT head was negative.  UA showed evidence of infection and Ucx grew 2 strains of E coli so he was started on ceftriaxone.  He had a CT urogram which showed 2 new bladder masses.  Urology was consulted and said workup can be done outpt.  He follows with Urology at other facility and he will decide if he wants to follow up with them or stay here for the workup.  During his stay he developed a gout flare and was started on a steroid taper along with colchicine.  His heart rate was elevated so Toprol dose was increased.  PT/OT recommended SNF.  Pt was stable on discharge.  He will be discharged.     Sepsis 2/2 UTI - elevated wbc and HR - sepsis resolved - Ucx growing E coli 2 strains - continue cefdinir 300mg BID for 3 more days   New bladder masses Hx of bladder cancer - s/p TURBT - CT urogram showed 2 new bladder masses  - follow up with Urology outpt for workup   Elevated Cr on CKD-3 - baseline Cr 1.4 - likely due to poor perfusion in setting of infection  - resolved    Gout flare - evidence of polyarticular disease with tophi - continue prednisone 40mg for 3 days, then 30mg for 3 days then 20mg for 3 days - start colchicine 0.6mg every other day - start allopurinol 100mg daily on 5/6/23 - referral placed to Rheumatology   Afib with RVR - CHADS-VASc- 3 - continue Eliquis 2.5mg BID - increased Toprol to 100mg daily, monitor HR and may need dose reduced   HTN - continue HCTZ 12.5mg daily, lisinopril 10mg nighlty and Toprol   HLD - continue atorvastatin 20mg daily   BPH - s/p HoLEP   Issues Requiring Follow Up: (Who, what, when, and how communicated?)    Follow up with PCP and Urology.  Referral placed to Rheumatology.  Complete 3 more days of antibiotics.  Complete steroid taper.  Start colchicine and allopurinol.  Toprol dose increased, monitor HR for dose adjustments.
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Escherichia test positive, Fall, Gout, Heart rate increased, Infection
Clinical narrative: Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)    This is a 86 yr old male with PMHx of CKD-3, gout, persistent Afib, HTN, HLD and BPH who presented for generalized weakness and falls.  CT head was negative.  UA showed evidence of infection and Ucx grew 2 strains of E coli so he was started on ceftriaxone.  He had a CT urogram which showed 2 new bladder masses.  Urology was consulted and said workup can be done outpt.  He follows with Urology at other facility and he will decide if he wants to follow up with them or stay here for the workup.  During his stay he developed a gout flare and was started on a steroid taper along with colchicine.  His heart rate was elevated so Toprol dose was increased.  PT/OT recommended SNF.  Pt was stable on discharge.  He will be discharged.     Sepsis 2/2 UTI - elevated wbc and HR - sepsis resolved - Ucx growing E coli 2 strains - continue cefdinir 300mg BID for 3 more days   New bladder masses Hx of bladder cancer - s/p TURBT - CT urogram showed 2 new bladder masses  - follow up with Urology outpt for workup   Elevated Cr on CKD-3 - baseline Cr 1.4 - likely due to poor perfusion in setting of infection  - resolved    Gout flare - evidence of polyarticular disease with tophi - continue prednisone 40mg for 3 days, then 30mg for 3 days then 20mg for 3 days - start colchicine 0.6mg every other day - start allopurinol 100mg daily on 5/6/23 - referral placed to Rheumatology   Afib with RVR - CHADS-VASc- 3 - continue Eliquis 2.5mg BID - increased Toprol to 100mg daily, monitor HR and may need dose reduced   HTN - continue HCTZ 12.5mg daily, lisinopril 10mg nighlty and Toprol   HLD - continue atorvastatin 20mg daily   BPH - s/p HoLEP   Issues Requiring Follow Up: (Who, what, when, and how communicated?)    Follow up with PCP and Urology.  Referral placed to Rheumatology.  Complete 3 more days of antibiotics.  Complete steroid taper.  Start colchicine and allopurinol.  Toprol dose increased, monitor HR for dose adjustments.
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Renal ischaemia, SARS-CoV-2 test positive, Sepsis, Urinary tract infection, Urine analysis abnormal
Clinical narrative: Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)    This is a 86 yr old male with PMHx of CKD-3, gout, persistent Afib, HTN, HLD and BPH who presented for generalized weakness and falls.  CT head was negative.  UA showed evidence of infection and Ucx grew 2 strains of E coli so he was started on ceftriaxone.  He had a CT urogram which showed 2 new bladder masses.  Urology was consulted and said workup can be done outpt.  He follows with Urology at other facility and he will decide if he wants to follow up with them or stay here for the workup.  During his stay he developed a gout flare and was started on a steroid taper along with colchicine.  His heart rate was elevated so Toprol dose was increased.  PT/OT recommended SNF.  Pt was stable on discharge.  He will be discharged.     Sepsis 2/2 UTI - elevated wbc and HR - sepsis resolved - Ucx growing E coli 2 strains - continue cefdinir 300mg BID for 3 more days   New bladder masses Hx of bladder cancer - s/p TURBT - CT urogram showed 2 new bladder masses  - follow up with Urology outpt for workup   Elevated Cr on CKD-3 - baseline Cr 1.4 - likely due to poor perfusion in setting of infection  - resolved    Gout flare - evidence of polyarticular disease with tophi - continue prednisone 40mg for 3 days, then 30mg for 3 days then 20mg for 3 days - start colchicine 0.6mg every other day - start allopurinol 100mg daily on 5/6/23 - referral placed to Rheumatology   Afib with RVR - CHADS-VASc- 3 - continue Eliquis 2.5mg BID - increased Toprol to 100mg daily, monitor HR and may need dose reduced   HTN - continue HCTZ 12.5mg daily, lisinopril 10mg nighlty and Toprol   HLD - continue atorvastatin 20mg daily   BPH - s/p HoLEP   Issues Requiring Follow Up: (Who, what, when, and how communicated?)    Follow up with PCP and Urology.  Referral placed to Rheumatology.  Complete 3 more days of antibiotics.  Complete steroid taper.  Start colchicine and allopurinol.  Toprol dose increased, monitor HR for dose adjustments.
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Urogram abnormal, White blood cell count increased
Clinical narrative: Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)    This is a 86 yr old male with PMHx of CKD-3, gout, persistent Afib, HTN, HLD and BPH who presented for generalized weakness and falls.  CT head was negative.  UA showed evidence of infection and Ucx grew 2 strains of E coli so he was started on ceftriaxone.  He had a CT urogram which showed 2 new bladder masses.  Urology was consulted and said workup can be done outpt.  He follows with Urology at other facility and he will decide if he wants to follow up with them or stay here for the workup.  During his stay he developed a gout flare and was started on a steroid taper along with colchicine.  His heart rate was elevated so Toprol dose was increased.  PT/OT recommended SNF.  Pt was stable on discharge.  He will be discharged.     Sepsis 2/2 UTI - elevated wbc and HR - sepsis resolved - Ucx growing E coli 2 strains - continue cefdinir 300mg BID for 3 more days   New bladder masses Hx of bladder cancer - s/p TURBT - CT urogram showed 2 new bladder masses  - follow up with Urology outpt for workup   Elevated Cr on CKD-3 - baseline Cr 1.4 - likely due to poor perfusion in setting of infection  - resolved    Gout flare - evidence of polyarticular disease with tophi - continue prednisone 40mg for 3 days, then 30mg for 3 days then 20mg for 3 days - start colchicine 0.6mg every other day - start allopurinol 100mg daily on 5/6/23 - referral placed to Rheumatology   Afib with RVR - CHADS-VASc- 3 - continue Eliquis 2.5mg BID - increased Toprol to 100mg daily, monitor HR and may need dose reduced   HTN - continue HCTZ 12.5mg daily, lisinopril 10mg nighlty and Toprol   HLD - continue atorvastatin 20mg daily   BPH - s/p HoLEP   Issues Requiring Follow Up: (Who, what, when, and how communicated?)    Follow up with PCP and Urology.  Referral placed to Rheumatology.  Complete 3 more days of antibiotics.  Complete steroid taper.  Start colchicine and allopurinol.  Toprol dose increased, monitor HR for dose adjustments.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  HYPOXIA  3/24/2022  --  RECURRENCE OF SAME SYMPTOMS
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive, Sinus congestion, Vaccine breakthrough infection
Clinical narrative: I experienced a breakthrough case of COVID-19 with minor symptoms such as runny nose and a cough almost like a sinus congestion, I decided to test for COVID-19 and tested positive, my symptoms cleared a couple days later.
Age: 62.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Arthritis, Condition aggravated, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: It seems like my arthritis pain has seemed to have gotten worse, especially in my feet, I thought I had broken my toe, it was swelling, I could not wear shoes, I had to but wide shoes to even be able to wear shoes comfortably. I made an appointment with the doctor who performed an exam, she said it wasn't broken, but it did feel like arthritis was in the toe. She gave me steroid shot, advised me take ibuprofen when I had a flare. I issue is not as bad but my feet do still hurt me, it's not as intense but the pain is there.